Předmět: |
|
Zdroj: |
Drug Week; 11/3/2023, p867-867, 1p |
Abstrakt: |
Keywords: Baltimore; State:Maryland; United States; North and Central America; Central Nervous System Diseases and Conditions; Drugs and Therapies; Emerging Technologies; Genetics; Health and Medicine; Inflammation; Nanopharmaceuticals; Nanotechnology; Nervous System Diseases and Conditions; Nervous System Heredodegenerative Disorders; Neurobehavioral Manifestations; Neurodegenerative Diseases and Conditions; Neurologic Manifestations; Rett Syndrome; X-Linked Mental Retardation EN Baltimore State:Maryland United States North and Central America Central Nervous System Diseases and Conditions Drugs and Therapies Emerging Technologies Genetics Health and Medicine Inflammation Nanopharmaceuticals Nanotechnology Nervous System Diseases and Conditions Nervous System Heredodegenerative Disorders Neurobehavioral Manifestations Neurodegenerative Diseases and Conditions Neurologic Manifestations Rett Syndrome X-Linked Mental Retardation 867 867 1 10/30/23 20231103 NES 231103 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A new study on Central Nervous System Diseases and Conditions - Rett Syndrome is now available. Glial cell dysfunction has been implicated in in Rett syndrome (RTT) both in patients and in mouse models of this disorder and can affect synaptogenesis, glial metabolism and inflammation.". [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|